ISLAMABAD: While setting aside its show-cause notice to Pharma Bureau (PB) for alleged cartelisation, the Competition Commission of Pakistan (CCP) has warned that the pharmaceutical sector is under its watch and any collusive or anti-competitive activity will be strictly dealt with...
In 2016, the commission took a suo motu notice and conducted an inquiry into allegations published in national press that a number of pharma...
US pharmaceutical company Gilead Sciences on Tuesday said that it was in talks with drug companies in Pakistan and India to start remdesivir production...
According to a statement on its website, Gilead Sciences "is negotiating long-term voluntary licenses with several generic drugmakers in India and Pakistan to produce remdesivir for developing countries...
In 1992, the editor of The Times of India telephoned one of Mumbai’s most prominent businessmen, Yusuf K Hamied...
The editor asked Hamied, “as a Muslim leader” his opinion on communal riots that were taking place in the city
KARACHI: The growth of pharmaceutical industry has dropped to around eight per cent per annum from approximately 16 per cent, said Pharma Bureau (PB) Chairman Arshad Saeed Hussain on Thursday...
Executive Director PB Ayesha Tammy Haq said that due to stringent regulatory control, particularly in price control, companies are leaving Pakistan...
LAHORE: Some pharmaceutical companies are involved in an illegal business of selling cardiac medicines, surgical items and orthopaedic implants at Jinnah Hospital with the alleged connivance of doctors and administration officials of the institute...
The companies have set up mobile pharmacies in the cardiology and orthopaedic departments of the hospital and cheating poor patients by selling life-saving drugs and surgical implants at...
NEW YORK: Less than an hour after a US jury convicted Martin Shkreli of securities fraud, the so-called “Pharma Bro” was back at his New York City apartment doing what comes naturally: trash talking in a live-stream on YouTube...
KARACHI: ICI Pakistan Ltd has executed an asset purchase agreement with Wyeth Pakistan Ltd and Pfizer Pakistan Ltd for the acquisition of certain assets at the aggregate purchase price of Rs1...
KARACHI: The business leaders of auto, cement and pharma sectors gave a mixed reaction to the split decision by a five-member bench of the Supreme Court on the Panama Papers case...
Pakistan Association of Auto Parts and Accessories Manufacturers (Paapam) Chairman Mashood Ali Khan said Pakistan needs political stability...
KARACHI: Despite pricing and policy constraints, pharmaceutical companies in Pakistan are producing quality drugs under the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Code of Conduct, a statement released by the representative body of pharma industry said...
During a visit to a GSK production facility in SITE, Karachi, Pharma Bureau (PB) representatives said that despite regulatory challenges,...
NEW YORK: Martin Shkreli, the former hedge fund manager vilified in nearly every corner of America for buying a pharmaceutical company and jacking up the price of a life-saving drug more than fifty-fold, was arrested on Thursday on securities fraud charges unrelated to the furore...
The boyish-looking 32-year-old entrepreneur — a relentlessly self-promoting figure who has called himself "the world's most eligible bachelor" on Twitter and...
KARACHI: The pharmaceutical industry, beset by suspension of Pakistan International Airlines flights, sees a tough week ahead if operations did not resume, as it relies on raw material imports from India and some other countries...
Former chairman of Pakistan Pharmaceutical Manufacturers Association (PPMA) Saeed Allawala said that the industry imports raw material worth $350-400 million per annum mainly from India, Europe and China......
ISLAMABAD: Even announcing its decision about four decades ago, the ministry of health has not yet formulated a policy to ensure multinational pharmaceutical companies produced raw materials in Pakistan and did not import them...
In the 60s, a number of companies came to Pakistan and established their manufacturing units in the country,” he said...
ISLAMABAD: Pharmaceutical companies have blamed the Drug Regulatory Authority of Pakistan (Drap) for the current shortage of certain medicines in the country...
Their representative body, the Pharma Bureau, urged the Drap in a statement on Tuesday to revise its mechanism for controlling the supply of Ephedrine, Pseudoephedrine and other Active Pharmaceutical Ingredients (API) that are used in manufacturing cough and cold syrups,...
A sparkling and sprawling 48,000-square-foot two-story structure, decorated with artwork of animals etched onto interior glass walls, recently opened its doors 23 miles outside Indianapolis with one sole purpose: to keep the globe’s 70 billion farm animals healthy...
That increasingly means less reliance on antibiotics for animals
The companies have recently raised prices after obtaining a stay order from the Sindh High Court (SHC) claiming that it was not viable for them to manufacture drugs at the rates fixed by the Drug Regulatory Authority of Pakistan (Drap)...
However, only Pakistan Pharmaceutical Manufacturers’ Association (PPMA) chairman Hamid Raza attended the meeting while the representatives of Pharma Bureau (the body of multinational companies) and...